prostate cancer

AstraZeneca Success On Prostate Cancer Drug Lowers Enthusiasm For Clovis
Yahoo/Benzinga
Wed, 08/14/19 - 10:13 am
AstraZeneca
Clovis Oncology
prostate cancer
Lynparza
Clovis investors feel more Lynparza pressure
EP Vantage
Thu, 08/8/19 - 10:51 am
prostate cancer
Lynparza
Rubraca
Clovis Oncology
AstraZeneca
Merck
AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race
Endpoints
Wed, 08/7/19 - 10:46 am
Lynparza
AstraZeenca
Merck
prostate cancer
clinical trials
Bayer's Prostate Cancer Drug Earns FDA Approval
BioSpace
Thu, 08/1/19 - 10:22 am
Bayer
Nubeqa
darolutamide
prostate cancer
Bayer, Orion win speedy approval for prostate cancer drug darolutamide
Endpoints
Wed, 07/31/19 - 08:51 am
Bayer
Orion
prostate cancer
darolutamide
FDA
Did cancer clinical trials stay on track at ASCO 2019?
Pharmaforum
Fri, 07/19/19 - 01:00 pm
ASCO
clinical trials
cancer
ASCO 2019
bladder cancer
breast cancer
prostate cancer
pancreatic cancer
Dementia tied to hormone-blocking prostate cancer treatment
Yahoo/AP
Sun, 07/7/19 - 10:25 pm
Alzheimer's disease
prostate cancer
Spotlight on: Exosome Diagnostics, first to develop RNA-based liquid biopsies
CP Wire
Wed, 06/5/19 - 07:28 pm
Exosome Diagnostics
diagnostics
Bio-Techne
prostate cancer
lung cancer
RNA
Spotlight on: Exosome Diagnostics, first to develop RNA-based liquid biopsies
Wed, 06/5/19 - 04:00 pm
Exosome Diagnostics
diagnostics
Bio-Techne
prostate cancer
lung cancer
RNA
ASCO: Pfizer, Astellas' Xtandi racks up more data for new prostate cancer approval
Fierce Pharma
Sun, 06/2/19 - 01:17 pm
Pfizer
Astellas
Xtandi
prostate cancer
ASCO 2019
AZ/Merck & Co reveal data supporting PARP drug in prostate cancer
Pharmaforum
Sat, 06/1/19 - 12:43 pm
ASCO 2019
AstraZeneca
Merck
prostate cancer
olaparib
ASCO 2019 day one
Pharmaforum
Fri, 05/31/19 - 11:46 am
ASCO 2019
JNJ
Erleada
AstraZeneca
Merck
Lynparza
prostate cancer
Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site
Fierce Pharma
Thu, 05/23/19 - 09:59 am
Dendreon
prostate cancer
Provenge
drug manufacturing
Marketing J&J eyes prostate cancer boost as FDA accepts Erleada for real-time review
Fierce Pharma
Fri, 05/3/19 - 10:43 pm
JNJ
Erleada
FDA
prostate cancer
metastatic castration-resistant prostate cancer
FDA tags Bayer's prostate cancer drug for priority review as drugmaker gears up against rivals
Endpoints
Mon, 04/29/19 - 12:02 pm
Bayer
Orion
prostate cancer
priority review
daralutamide
FDA
miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer
CP Wire
Mon, 03/18/19 - 10:28 am
miR Scientific
prostate cancer
bladder cancer
miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer
Mon, 03/18/19 - 10:27 am
miR Scientific
prostate cancer
bladder cancer
Blood Test Study Meets Goal, Validates Epic’s Prostate Cancer Target
Xconomy
Thu, 03/14/19 - 09:52 am
Epic Sciences
diagnostics
prostate cancer
Bayer files prostate cancer drug darolutamide with EU regulators
Pharmaforum
Mon, 03/11/19 - 10:06 am
Bayer
Europe
darolutamide
prostate cancer
Bayer files prostate cancer drug darolutamide in Japan
Pharmaforum
Tue, 03/5/19 - 10:02 am
Bayer
prostate cancer
darolutamide
Japan
JNJ
Pfizer
Astellas

Pages